# OM (Outset Medical, Inc.) - SEC EDGAR Financial Statements

> Outset Medical, Inc. reported $122.0M in revenue and a net loss of $71.14M for the trailing twelve months ended September 30, 2026 (up 14.2% year over year), with a 42.0% gross margin and a -51.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/OM
- Markdown: https://convexityos.com/fundamentals/OM.md
- SEC CIK: 0001484612
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001484612&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $122.0M | +14.2% YoY |
| Operating Income | TTM | -$62.49M | -51.2% margin |
| Net Income | TTM | -$71.14M | -58.3% net margin |
| Diluted EPS | TTM | -$3,777.76 | Split-adjusted |
| Free Cash Flow | TTM | -$42.89M | -35.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $136.6M | Total debt: $104.8M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M | $49.94M | $15.08M | $2.01M |
| Cost of Revenue | $72.72M | $75.12M | $101.4M | $97.54M | $94.99M | $62.97M | $32.88M | $8.12M |
| **Gross Profit** | $46.75M | $38.56M | $29.00M | $17.83M | $7.61M | -$13.04M | -$17.80M | -$6.12M |
| Research & Development | $21.23M | $38.40M | $57.31M | $48.85M | $36.74M | $28.85M | $23.33M | $22.92M |
| Selling, General & Admin | $92.22M | $113.5M | $141.5M | $130.0M | $101.4M | $75.58M | $29.18M | $17.53M |
| Total Operating Expenses | $113.5M | $151.9M | $198.8M | $178.9M | $138.1M | $104.4M | $52.51M | $40.45M |
| **Operating Income** | -$66.71M | -$113.4M | -$169.8M | -$161.0M | -$130.5M | -$117.5M | -$70.31M | -$46.56M |
| **EBITDA** | -$62.37M | -$107.6M | -$164.0M | -$155.8M | -$125.4M | -$114.3M | -$68.82M | -$45.49M |
| Interest Expense | $13.95M | $23.87M | $12.68M | $3.57M | $1.72M | $2.89M | $4.26M | $4.64M |
| Income Before Tax | -$80.94M | -$127.5M | -$172.3M | -$162.7M | -$131.7M | -$121.5M | -$68.28M | -$49.76M |
| Income Tax Expense | $718K | $491K | $523K | $295K | $199K | $0 | $20K | $25K |
| **Net Income** | -$81.65M | -$128.0M | -$172.8M | -$163.0M | -$131.9M | -$121.5M | -$68.30M | -$49.78M |
| Basic EPS | -$5.37 | -$36.96 | -$52.28 | -$50.70 | -$43.35 | -$72.75 | -$1,493.70 | -$1,511.25 |
| **Diluted EPS** | -$5.37 | -$36.96 | -$52.28 | -$50.70 | -$43.35 | -$72.75 | -$1,493.70 | -$1,511.25 |
| Basic Shares Outstanding | 15.2K | 3.5K | 3.3K | 3.2K | 3.0K | 1.1K | 57.2K | 48.3K |
| Diluted Shares Outstanding | 15.2K | 3.5K | 3.3K | 3.2K | 3.0K | 1.1K | 57.2K | 48.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $33.60M | $31.64M | $27.86M | $28.87M | $29.43M | $31.42M | $29.75M | $29.47M |
| Cost of Revenue | $19.93M | $18.35M | $15.77M | $16.64M | $17.84M | $19.55M | $18.69M | $18.72M |
| **Gross Profit** | $13.67M | $13.28M | $12.10M | $12.23M | $11.59M | $11.87M | $11.07M | $10.75M |
| Research & Development | $5.90M | $5.45M | $5.62M | $5.05M | $5.38M | $5.29M | $5.51M | $7.89M |
| Selling, General & Admin | $20.04M | $23.51M | $23.40M | $24.80M | $22.03M | $23.44M | $21.95M | $24.72M |
| Total Operating Expenses | $25.94M | $28.96M | $29.01M | $29.86M | $27.40M | $28.73M | $27.46M | $32.61M |
| **Operating Income** | -$12.27M | -$15.68M | -$16.92M | -$17.63M | -$15.81M | -$16.86M | -$16.40M | -$21.86M |
| **EBITDA** | -$11.60M | -$15.05M | -$16.12M | -$16.75M | -$14.80M | -$15.71M | -$15.11M | -$20.45M |
| Interest Expense | $3.50M | $3.44M | $3.37M | $3.44M | $3.48M | $3.48M | $3.56M | $5.83M |
| Income Before Tax | -$14.53M | -$17.76M | -$18.76M | -$19.40M | -$17.43M | -$18.44M | -$25.67M | -$25.64M |
| Income Tax Expense | $153K | $220K | $217K | $95K | $404K | $104K | $115K | -$4.0K |
| **Net Income** | -$14.69M | -$17.98M | -$18.98M | -$19.49M | -$17.84M | -$18.54M | -$25.78M | -$25.64M |
| Basic EPS | -$0.78 | -$0.97 | -$1.03 | -- | -$1.00 | -$1.04 | -$3.66 | -- |
| **Diluted EPS** | -$0.78 | -$0.97 | -$1.03 | -- | -$1.00 | -$1.04 | -$3.66 | -- |
| Basic Shares Outstanding | 18.8K | 18.6K | 18.4K | -- | 17.8K | 17.7K | 7.0K | -- |
| Diluted Shares Outstanding | 18.8K | 18.6K | 18.4K | -- | 17.8K | 17.7K | 7.0K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35.01M | $124.0M | $68.51M | $73.22M | $182.3M | $295.0M | $36.93M |
| Short-Term Investments | $133.9M | $34.67M | $134.8M | $214.3M | $157.1M | $19.90M | $33.15M |
| **Cash & Short-Term Investments** | $168.9M | $158.7M | $203.3M | $287.5M | $339.5M | $314.9M | $70.08M |
| Accounts Receivable, Net | $28.33M | $35.62M | $32.98M | $28.07M | $25.60M | $6.47M | $3.91M |
| Inventory | $47.61M | $59.39M | $49.22M | $51.48M | $39.19M | $18.38M | $4.60M |
| **Total Current Assets** | $250.9M | $258.2M | $291.2M | $373.6M | $409.8M | $345.9M | $79.65M |
| Property, Plant & Equipment, Net | $4.67M | $8.13M | $13.27M | $15.88M | $12.96M | $15.00M | $7.89M |
| Other Non-Current Assets | $317K | $2.17M | $605K | $1.17M | $156K | $1.36M | $82K |
| **Total Non-Current Assets** | $13.61M | $17.57M | $22.58M | $26.47M | $53.66M | $57.92M | $8.72M |
| **Total Assets** | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M | $403.8M | $88.37M |
| Accounts Payable | $554K | $3.86M | $5.83M | $603K | $1.76M | $4.95M | $4.96M |
| Short-Term Debt | -- | -- | -- | $4.75M | $2.02M | $2.02M | $7.50M |
| Deferred Revenue (Current) | $13.79M | $12.75M | $11.73M | $8.66M | $6.34M | $3.20M | $883K |
| Other Current Liabilities | $4.07M | $3.09M | $5.76M | $7.11M | $4.02M | $1.40M | $1.14M |
| **Total Current Liabilities** | $37.63M | $45.38M | $55.32M | $51.95M | $51.70M | $36.69M | $24.91M |
| Long-Term Debt | $96.24M | $197.4M | $130.1M | $96.34M | $29.76M | $29.67M | $21.56M |
| Deferred Revenue (Non-Current) | $406K | $844K | $101K | $151K | $312K | $570K | $134K |
| **Total Non-Current Liabilities** | $99.91M | $203.6M | $135.6M | $102.2M | $37.69M | $38.53M | $26.20M |
| **Total Liabilities** | $137.5M | $249.0M | $190.9M | $154.1M | $89.38M | $75.22M | $51.11M |
| **Total Debt (incl. Leases)** | $101.2M | $201.9M | $136.2M | $108.0M | $39.83M | $40.62M | $29.07M |
| Common Stock | $18K | $4.0K | $50K | $48K | $47K | $43K | $1.0K |
| Retained Earnings | -$1.17B | -$1.09B | -$961.7M | -$789.0M | -$626.0M | -$494.1M | -$372.6M |
| Accumulated Other Comp. Income | $172K | $42K | $68K | -$564K | -$184K | $1.0K | $22K |
| **Total Stockholders' Equity** | $127.0M | $26.82M | $122.9M | $246.0M | $374.1M | $328.6M | -$372.2M |
| Total Equity | $127.0M | $26.82M | $122.9M | $246.0M | $374.1M | $328.6M | -$372.2M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $33.94M | $35.01M | $30.56M | $35.01M | $36.44M | $39.56M | $75.93M | $124.0M |
| Short-Term Investments | $102.7M | $112.2M | $126.1M | $133.9M | $142.2M | $144.5M | $113.1M | $34.67M |
| **Cash & Short-Term Investments** | $136.6M | $147.2M | $156.7M | $168.9M | $178.6M | $184.1M | $189.0M | $158.7M |
| Accounts Receivable, Net | $30.41M | $29.22M | $25.32M | $28.33M | $32.96M | $34.89M | $36.89M | $35.62M |
| Inventory | $44.99M | $47.31M | $49.65M | $47.61M | $49.29M | $52.25M | $55.77M | $59.39M |
| **Total Current Assets** | $216.2M | $227.8M | $236.7M | $250.9M | $265.4M | $275.6M | $286.6M | $258.2M |
| Property, Plant & Equipment, Net | $3.54M | $3.71M | $4.07M | $4.67M | $5.25M | $6.17M | $6.94M | $8.13M |
| Other Non-Current Assets | $447K | $411K | $353K | $317K | $538K | $560K | $818K | $2.17M |
| **Total Non-Current Assets** | $14.19M | $14.54M | $12.74M | $13.61M | $11.89M | $13.22M | $14.65M | $17.57M |
| **Total Assets** | $230.4M | $242.4M | $249.5M | $264.5M | $277.3M | $288.8M | $301.2M | $275.8M |
| Accounts Payable | $4.29M | $4.46M | $1.44M | $554K | $1.72M | $1.45M | $1.17M | $3.86M |
| Deferred Revenue (Current) | $13.47M | $14.04M | $12.64M | $13.79M | $14.90M | $14.01M | $13.19M | $12.75M |
| Other Current Liabilities | $5.28M | $6.02M | $5.08M | $4.07M | $3.56M | $3.19M | $2.73M | $3.09M |
| **Total Current Liabilities** | $44.45M | $43.89M | $37.61M | $37.63M | $37.45M | $36.91M | $34.22M | $45.38M |
| Long-Term Debt | $98.37M | $97.65M | $96.94M | $96.24M | $95.52M | $94.81M | $94.11M | $197.4M |
| Deferred Revenue (Non-Current) | $221K | $302K | $366K | $406K | $676K | $587K | $804K | $844K |
| **Total Non-Current Liabilities** | $102.6M | $102.2M | $100.2M | $99.91M | $97.44M | $97.11M | $97.12M | $203.6M |
| **Total Liabilities** | $147.1M | $146.0M | $137.8M | $137.5M | $134.9M | $134.0M | $131.3M | $249.0M |
| **Total Debt (incl. Leases)** | $104.8M | $104.4M | $101.6M | $101.2M | $98.68M | $98.43M | $98.17M | $201.9M |
| Common Stock | $19K | $19K | $18K | $18K | $18K | $18K | $18K | $4.0K |
| Retained Earnings | -$1.22B | -$1.21B | -$1.19B | -$1.17B | -$1.15B | -$1.13B | -$1.12B | -$1.09B |
| Accumulated Other Comp. Income | -$244K | -$136K | -$73K | $172K | $157K | $49K | $88K | $42K |
| **Total Stockholders' Equity** | $83.31M | $96.34M | $111.7M | $127.0M | $142.4M | $154.8M | $169.9M | $26.82M |
| Total Equity | $83.31M | $96.34M | $111.7M | $127.0M | $142.4M | $154.8M | $169.9M | $26.82M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$81.65M | -$128.0M | -$172.8M | -$163.0M | -$131.9M | -$121.5M | -$68.30M | -$49.78M |
| Depreciation & Amortization | $4.34M | $5.73M | $5.81M | $5.17M | $5.16M | $3.16M | $1.48M | $1.07M |
| Stock-Based Compensation | $15.62M | $29.36M | $38.63M | $27.20M | $17.45M | $21.44M | $883K | $788K |
| Change in Receivables | $3.77M | -$5.01M | -$5.09M | -$2.51M | -$19.14M | -$2.57M | -$2.89M | -$552K |
| Change in Inventory | $11.79M | -$10.86M | $1.65M | -$14.73M | -$22.04M | -$16.29M | -$5.02M | -$2.21M |
| Change in Payables | -$3.29M | -$1.95M | $5.31M | -$1.28M | -$3.07M | $737K | $802K | $2.67M |
| **Operating Cash Flow** | -$46.33M | -$116.3M | -$131.4M | -$145.7M | -$130.3M | -$99.02M | -$70.29M | -$46.44M |
| Capital Expenditure | -$798K | -$912K | -$3.44M | -$8.32M | -$3.11M | -$9.08M | -$3.29M | -$1.77M |
| **Free Cash Flow** | -$47.12M | -$117.2M | -$134.8M | -$154.1M | -$133.4M | -$108.1M | -$73.58M | -$48.21M |
| Purchases of Investments | -$222.0M | -$156.6M | -$172.3M | -$261.2M | -$178.4M | -$32.88M | -$91.88M | -- |
| Sales & Maturities of Investments | $125.1M | $261.4M | $258.8M | $203.2M | $39.03M | $45.91M | $169.5M | -- |
| **Investing Cash Flow** | -$97.68M | $103.9M | $83.03M | -$66.30M | -$142.5M | $3.95M | $74.30M | -$68.78M |
| Common Stock Issued | -- | -- | $0 | $0 | $149.1M | $254.8M | -- | -- |
| **Financing Cash Flow** | $55.50M | $67.87M | $43.65M | $72.90M | $160.1M | $385.7M | $249K | $134.9M |
| **Net Change in Cash** | -$88.51M | $55.51M | -$4.70M | -$139.1M | -$112.6M | $290.6M | $4.25M | $19.65M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.69M | -$17.98M | -$18.98M | -$19.49M | -$17.84M | -$18.54M | -$25.78M | -$25.64M |
| Depreciation & Amortization | $666K | $627K | $795K | $881K | $1.01M | $1.16M | $1.29M | $1.41M |
| Stock-Based Compensation | $1.69M | $2.70M | $3.45M | $4.06M | $5.08M | $3.50M | $2.98M | $4.95M |
| Change in Receivables | -$2.09M | -$5.04M | $3.41M | $1.77M | $2.90M | $574K | -$1.47M | -$1.92M |
| Change in Inventory | $2.19M | $2.34M | -$2.24M | $1.49M | $3.00M | $3.61M | $3.69M | $2.13M |
| Change in Payables | -$96K | $2.97M | $865K | -$1.13M | $338K | $270K | -$2.77M | -$441K |
| **Operating Cash Flow** | -$10.38M | -$9.63M | -$12.84M | -$9.52M | -$6.32M | -$4.82M | -$25.66M | -$16.49M |
| Capital Expenditure | -$109K | -$111K | -$65K | -$223K | -$160K | -$292K | -$123K | -$43K |
| **Free Cash Flow** | -$10.49M | -$9.75M | -$12.91M | -$9.74M | -$6.48M | -$5.12M | -$25.79M | -$16.53M |
| Purchases of Investments | -$24.09M | -$18.65M | -$22.89M | -$28.22M | -$40.09M | -$57.32M | -$96.33M | -$6.12M |
| Sales & Maturities of Investments | $33.87M | $32.92M | $30.86M | $37.03M | $43.22M | $26.45M | $18.38M | $114.3M |
| **Investing Cash Flow** | $9.66M | $14.17M | $7.90M | $8.59M | $2.97M | -$31.16M | -$78.08M | $108.2M |
| **Financing Cash Flow** | -$56K | -$88K | $501K | $0 | $231K | -$384K | $55.66M | -$938K |
| **Net Change in Cash** | -$771K | $4.44M | -$4.44M | -$931K | -$3.12M | -$36.37M | -$48.09M | $90.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 39.1% | 33.9% | 22.2% | 15.5% | 7.4% | -26.1% | -118.1% | -304.7% |
| **Operating Margin** | -55.8% | -99.7% | -130.2% | -139.6% | -127.2% | -235.2% | -466.3% | -2320.0% |
| **Net Profit Margin** | -68.3% | -112.6% | -132.5% | -141.2% | -128.6% | -243.3% | -453.0% | -2480.3% |
| Return on Equity (ROE) | -64.3% | -477.2% | -140.6% | -66.2% | -35.3% | -37.0% | -- | -- |
| Return on Assets (ROA) | -30.9% | -46.4% | -55.1% | -40.7% | -28.5% | -30.1% | -77.3% | -- |
| Current Ratio | 6.67x | 5.69x | 5.26x | 7.19x | 7.93x | 9.43x | 3.20x | -- |
| Quick Ratio | 5.40x | 4.38x | 4.37x | 6.20x | 7.17x | 8.93x | 3.01x | -- |
| Debt to Equity | 0.80x | 7.53x | 1.11x | 0.44x | 0.11x | 0.12x | -- | -- |
| **Revenue Growth (YoY)** | +5.1% | -12.8% | +13.0% | +12.4% | +105.5% | +231.2% | +651.3% | -- |
| Gross Profit Growth (YoY) | +21.2% | +33.0% | +62.6% | +134.4% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -82.8% | +12354.3% | +94899.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 42.0% | 41.8% | 40.6% | 39.1% | 37.7% | 36.5% | 35.9% | 33.9% |
| **Operating Margin** | -51.2% | -56.1% | -57.2% | -55.8% | -59.1% | -66.2% | -80.6% | -99.7% |
| **Net Profit Margin** | -58.3% | -63.1% | -63.7% | -68.3% | -73.1% | -82.1% | -98.7% | -112.6% |
| Return on Equity (ROE) | -85.4% | -77.1% | -67.0% | -64.3% | -61.7% | -63.3% | -67.0% | -477.2% |
| Return on Assets (ROA) | -30.9% | -30.6% | -30.0% | -30.9% | -31.7% | -33.9% | -37.8% | -46.4% |
| Current Ratio | 4.86x | 5.19x | 6.29x | 6.67x | 7.09x | 7.47x | 8.37x | 5.69x |
| Quick Ratio | 3.85x | 4.11x | 4.97x | 5.40x | 5.77x | 6.05x | 6.74x | 4.38x |
| Debt to Equity | 1.26x | 1.08x | 0.91x | 0.80x | 0.69x | 0.64x | 0.58x | 7.53x |
| **Revenue Growth (YoY)** | +14.2% | +0.7% | -6.3% | -2.0% | +2.7% | +14.7% | +5.6% | -3.4% |
| Gross Profit Growth (YoY) | +18.0% | +11.9% | +9.3% | +13.8% | +18.0% | +21.3% | +34.7% | +39.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
